{"id":"https://openalex.org/W4229456992","doi":"https://doi.org/10.1007/s40122-022-00384-y","title":"Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies","display_name":"Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies","publication_year":2022,"publication_date":"2022-05-10","ids":{"openalex":"https://openalex.org/W4229456992","doi":"https://doi.org/10.1007/s40122-022-00384-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/35538185","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9314481"},"language":"en","primary_location":{"id":"doi:10.1007/s40122-022-00384-y","doi":"https://doi.org/10.1007/s40122-022-00384-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40122-022-00384-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40122-022-00384-y.pdf","source":{"id":"https://openalex.org/S4210201874","display_name":"Pain and Therapy","issn_l":"2193-8237","issn":["2193-8237","2193-651X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40122-022-00384-y.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101920043","display_name":"Kenji Miki","orcid":"https://orcid.org/0000-0002-9017-413X","observed_orcids":["https://orcid.org/0000-0002-9017-413X"]},"institutions":[{"id":"https://openalex.org/I4210130925","display_name":"Osaka Yukioka Medical University","ror":"https://ror.org/02ypyf569","country_code":"JP","type":"education","lineage":["https://openalex.org/I4210130925"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Miki","raw_affiliation_strings":["Osaka Yukioka College of Health Science, Hayaishi Hospital, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osaka Yukioka College of Health Science, Hayaishi Hospital, Osaka, Japan","institution_ids":["https://openalex.org/I4210130925"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Makoto Ohta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Makoto Ohta","raw_affiliation_strings":["Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan. Makoto.Ohta@pfizer.com","Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan. Makoto.Ohta@pfizer.com","institution_ids":["https://openalex.org/I4210148786"]},{"raw_affiliation_string":"Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087548495","display_name":"Manabu Abe","orcid":"https://orcid.org/0000-0002-2013-4394","observed_orcids":["https://orcid.org/0000-0002-2013-4394"]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Manabu Abe","raw_affiliation_strings":["Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081787069","display_name":"Hiroki Yoshimatsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroki Yoshimatsu","raw_affiliation_strings":["Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081879009","display_name":"Koichi Fujii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichi Fujii","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006595010","display_name":"Nozomi Ebata","orcid":"https://orcid.org/0000-0003-3842-2578","observed_orcids":["https://orcid.org/0000-0003-3842-2578"]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nozomi Ebata","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089760100","display_name":"Christine R. West","orcid":"https://orcid.org/0000-0001-9447-2911","observed_orcids":["https://orcid.org/0000-0001-9447-2911"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine R. West","raw_affiliation_strings":["Pfizer Inc., Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102834751","display_name":"Mark T. Brown","orcid":"https://orcid.org/0000-0002-9618-2480","observed_orcids":["https://orcid.org/0000-0002-9618-2480"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark T. Brown","raw_affiliation_strings":["Pfizer Inc., Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020898892","display_name":"Glenn C. Pixton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glenn Pixton","raw_affiliation_strings":["Pfizer Inc., Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056355036","display_name":"Naoki Isogawa","orcid":"https://orcid.org/0000-0003-4529-4834","observed_orcids":["https://orcid.org/0000-0003-4529-4834"]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Isogawa","raw_affiliation_strings":["Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer R&D Japan, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210148786"],"apc_list":{"value":6000,"currency":"USD","value_usd":6000},"apc_paid":{"value":6000,"currency":"USD","value_usd":6000},"fwci":0.306,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.49796513,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"11","issue":"3","first_page":"827","last_page":"844"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10105","display_name":"Osteoarthritis Treatment and Mechanisms","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10105","display_name":"Osteoarthritis Treatment and Mechanisms","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10084","display_name":"Musculoskeletal pain and rehabilitation","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/3612","display_name":"Physical Therapy, Sports Therapy and Rehabilitation"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tanezumab","display_name":"tanezumab","score":0.9589999914169312},{"id":"https://openalex.org/keywords/osteoarthritis","display_name":"osteoarthritis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/nerve-growth-factor","display_name":"nerve growth factor","score":0.6899999976158142},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6600000262260437},{"id":"https://openalex.org/keywords/joint-safety","display_name":"joint safety","score":0.7269999980926514},{"id":"https://openalex.org/keywords/pathological-fracture","display_name":"pathological fracture","score":0.7710000276565552},{"id":"https://openalex.org/keywords/subchondral-insufficiency-fracture","display_name":"subchondral insufficiency fracture","score":0.9929999709129333},{"id":"https://openalex.org/keywords/womac-pain","display_name":"WOMAC pain","score":0.6679999828338623},{"id":"https://openalex.org/keywords/nsaid-comparison","display_name":"NSAID comparison","score":0.6269999742507935},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8029999732971191}],"concepts":[{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.6810449957847595},{"id":"https://openalex.org/C2776164576","wikidata":"https://www.wikidata.org/wiki/Q62736","display_name":"Osteoarthritis","level":3,"score":0.6522163152694702},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5496934652328491},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.48708367347717285},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4743976593017578},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.46242088079452515},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36249810457229614},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.282020628452301},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.20899426937103271},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.18848684430122375},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10252299904823303},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.08941072225570679},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s40122-022-00384-y","doi":"https://doi.org/10.1007/s40122-022-00384-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40122-022-00384-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40122-022-00384-y.pdf","source":{"id":"https://openalex.org/S4210201874","display_name":"Pain and Therapy","issn_l":"2193-8237","issn":["2193-8237","2193-651X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain and Therapy","raw_type":"journal-article"},{"id":"pmid:35538185","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35538185","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9314481","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9314481/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s40122-022-00384-y","doi":"https://doi.org/10.1007/s40122-022-00384-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40122-022-00384-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40122-022-00384-y.pdf","source":{"id":"https://openalex.org/S4210201874","display_name":"Pain and Therapy","issn_l":"2193-8237","issn":["2193-8237","2193-651X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4229456992.pdf","grobid_xml":"https://content.openalex.org/works/W4229456992.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1024353895","https://openalex.org/W1575211640","https://openalex.org/W1599185368","https://openalex.org/W1967057044","https://openalex.org/W1978358625","https://openalex.org/W2006781541","https://openalex.org/W2011413868","https://openalex.org/W2024014722","https://openalex.org/W2058147305","https://openalex.org/W2058875156","https://openalex.org/W2072664081","https://openalex.org/W2081338578","https://openalex.org/W2096388167","https://openalex.org/W2097699861","https://openalex.org/W2218583659","https://openalex.org/W2613818341","https://openalex.org/W2616840386","https://openalex.org/W2944867857","https://openalex.org/W2954490590","https://openalex.org/W3014194256","https://openalex.org/W3126946716","https://openalex.org/W3138064620","https://openalex.org/W4241041574","https://openalex.org/W4243219728","https://openalex.org/W7053224337"],"related_works":["https://openalex.org/W2951405928","https://openalex.org/W1978358625","https://openalex.org/W3014194256","https://openalex.org/W3034802231","https://openalex.org/W2922054715","https://openalex.org/W3156808925","https://openalex.org/W4386242925","https://openalex.org/W3020582855","https://openalex.org/W2782039957","https://openalex.org/W3153623421"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Tanezumab":[1],"is":[2,11],"a":[3,240],"monoclonal":[4],"antibody":[5],"against":[6],"nerve":[7],"growth":[8],"factor":[9],"that":[10],"under":[12],"investigation":[13],"for":[14,72,142],"the":[15,84,223,303,310],"treatment":[16],"of":[17,25,40,206,242,282,298],"osteoarthritis":[18,157],"(OA)":[19],"pain.":[20],"We":[21],"conducted":[22],"subgroup":[23,305],"analyses":[24],"two":[26],"randomized":[27],"phase":[28],"3":[29],"studies":[30],"to":[31,238],"summarize":[32],"efficacy,":[33],"general":[34],"safety,":[35],"and":[36,87,96,107,184,197,219,284,294],"adjudicated":[37,148,237,280],"joint":[38,150],"safety":[39,151,225],"tanezumab":[41,56,132,181,214,251,264,289],"in":[42,83,191],"Japanese":[43,174,304],"patients":[44,53,129,175,235],"with":[45,180,288,296,309],"moderate-to-severe":[46],"OA.":[47],"METHODS:":[48],"In":[49,125,222],"Study":[50,126,172],"1":[51,159,228],"(NCT02528188),":[52],"received":[54,130],"subcutaneous":[55,131],"2.5":[57,133,182,215,246,259,274],"mg":[58,61,183,186,247,253,260,266,275],"or":[59,65,137,166,270,292],"5":[60,135,185,217,252,265],"every":[62,139],"8":[63,140],"weeks":[64,141],"daily":[66],"oral":[67],"nonsteroidal":[68],"anti-inflammatory":[69],"drugs":[70],"(NSAID)":[71],"56":[73],"weeks.":[74,144],"The":[75],"co-primary":[76],"efficacy":[77],"endpoints":[78],"were":[79,210,236,286,306],"change":[80],"from":[81,302],"baseline":[82],"Western":[85],"Ontario":[86],"McMaster":[88],"Universities":[89],"Osteoarthritis":[90],"Index":[91],"(WOMAC)":[92],"Pain":[93],"subscale":[94,100],"score":[95,101,117],"WOMAC":[97,192,194],"Physical":[98,195],"Function":[99],"at":[102,118,202],"Week":[103,119,203],"16":[104,120],"(overall":[105,121],"study":[106,122,312],"Japan-specific":[108],"endpoints)":[109],"as":[110,112],"well":[111],"Patient":[113],"Global":[114],"Assessment":[115],"(PGA)-OA":[116],"endpoint":[123,152],"only).":[124],"2":[127],"(NCT02709486),":[128],"mg,":[134,136,216,218],"placebo":[138,293],"24":[143],"Safety":[145],"monitoring":[146],"included":[147],"composite":[149],"(CJSE)":[153],"including":[154],"rapidly":[155],"progressive":[156],"type":[158],"(RPOA1),":[160],"RPOA2,":[161],"primary":[162,271],"osteonecrosis,":[163],"pathological":[164],"fracture,":[165],"subchondral":[167],"insufficiency":[168],"fracture.":[169],"RESULTS:":[170],"For":[171],"1,":[173],"(n":[176,248,254,261,267,276],"=":[177,232,249,255,262,268,277],"200)":[178],"treated":[179],"showed":[187],"numerically":[188],"greater":[189],"improvements":[190],"Pain,":[193],"Function,":[196],"PGA-OA":[198],"scores":[199],"versus":[200],"NSAID":[201,220,291],"16.":[204],"Incidences":[205],"treatment-emergent":[207],"adverse":[208],"events":[209],"generally":[211,307],"similar":[212],"between":[213],"groups.":[221],"integrated":[224],"analysis":[226],"(Studies":[227],"+":[229],"2;":[230],"n":[231],"306),":[233],"ten":[234],"have":[239],"component":[241],"CJSE:":[243],"RPOA1":[244,283],"[tanezumab":[245,258,273],"2),":[250],"5)],":[256],"RPOA2":[257,285],"1),":[263],"1)],":[269],"osteonecrosis":[272],"1)].":[278],"Time-adjusted":[279],"rates":[281],"higher":[287],"than":[290],"increased":[295],"dose":[297],"tanezumab.":[299],"CONCLUSION:":[300],"Observations":[301],"consistent":[308],"overall":[311],"populations.":[313]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2022-05-11T00:00:00"}